Elironrasib
1-[4-(dimethylamino)-4-methylpent-2-ynoyl]-N-[(2S)-1-[[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-4-fluoro-N-methylpiperidine-4-carboxamide
Molecular Identity
Elironrasib
1-[4-(dimethylamino)-4-methylpent-2-ynoyl]-N-[(2S)-1-[[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-4-fluoro-N-methylpiperidine-4-carboxamide
PubChem CID: 156336120
2D Structure
Properties
C55H78FN9O8
Molecular Formula
1012.30
Molecular Weight
g/mol
1011.5957
Exact Mass
Da
5.6
XLogP
Above Lipinski threshold
171
TPSA
May have limited oral absorption
2
H-Bond Donors
13
H-Bond Acceptors
2040
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Elironrasib2641998-63-0942KVV5CJPRefChem:1084071RMC-6291GTPL12622RMC6291elironrasib [INN]CHEMBL5437500SCHEMBL23325010GLXC-27384EX-A7663NSC851965AT45105NSC-851965
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Elironrasib
Loading drug network...